INTRODUCTION Because cervical cancer is the leading cause of cancer mortality in Honduras, this study assessed knowledge, attitudes and barriers to cervical cancer screening services by Papanicolaou smear (pap smear) for women in rural, remote Honduras served by Virginia Commonwealth University's Global Health and Health Disparities Program (GH2DP). METHODS Two interviewers administered an in...

Cytological screening for cervical cancer (the Pap smear), the first attempt at mass screening for a human malignancy, is often presented as a non-problematic demonstration of the feasibility of such screening. Screening for this tumor became a model for screening for other malignancies: breast, colon and prostate. My text follows the early history of the Pap smear and the conditions that led t...

Background. Against a background of concern over the costs of the cervical screening programme in the United Kingdom, increased precision in targeting groups at high risk of having an abnormal cervical smear offers a means of increasing efficiency. Previous papers have described the development of a risk scoring system and its feasibility and reliability in primary care. Aim. A study was carrie...

The Polarprobe is a portable non invasive electronic device designed for the detection of cervical precancer and cancer. It measures both electrical and optical properties of cervical tissue to allow a real time comparison with a databank of previously determined cervical tissue types. The need for additional tests to augment or even replace the Papanicolaou smear has partly prompted its develo...

Screening is the basic practice in cancer prevention for cervical cancer. In the gynecology field, there are several alternative techniques for screening for pre-cancerous lesions for cervical cancer, including the Pap smear, visual inspection with acetic acid (VIA), human papilloma virus (HPV) DNA testing and combined Pap smear and VIA. In this work, the author focused on cost effectiveness an...

OBJECTIVE To assess which of three triage strategies for women with borderline abnormal cervical smear results in the best psychosocial outcomes. DESIGN Pragmatic, non-blinded, multicentre, randomised controlled trial. SETTING 18 family planning clinics across Australia, covering both urban and rural areas, between January 2004 and October 2006. PARTICIPANTS Women aged 16-70 years (n=314)...

conclusions our study shows that prevalence of hpv infection in cervical biopsy samples collected from suspected patients in khouzestan province is slightly higher than other provinces of iran. since hpv cervical infection, is an indicator for the host cervical cancer progression, parallel with pap smear test, pcr detection of hpv dna in biopsy of suspected cases is recommended. results out of ...

Women patients admitted to a district general hospital with non-gynaecological conditions were offered a cervical smear test. In three years 2296 women were tested. Serious uterine pathology was detected in 13 patients (5.7 per 1000) and significant cytological abnormalities (dyskaryosis of all grades) in 46 (20.0 per 1000). Of the women screened 963 (41.9%) had never had a smear test before an...

Even though a great attention has been given on the cervical cancer diagnosis, it is a tuff task to observe the pap smear slide through microscope. Image Processing and Machine learning techniques helps the pathologist to take proper decision. In this paper, we presented the diagnosis method using cervical cell image which is obtained by Pap smear test. Image segmentation performed by multi-thr...